Literature DB >> 2168911

Giant axonal neuropathy: clinical, electrophysiologic, and neuropathologic features in two siblings.

K Kumar1, P Barre, M Nigro, M Z Jones.   

Abstract

Giant axonal neuropathy is a progressive central-peripheral axonopathy characterized by distention of axons by aggregated neurofilaments. We report two female siblings with giant axonal neuropathy. Both patients developed symptoms of a chronic progressive polyneuropathy at age 3 years. Clinical evidence of central nervous system involvement was present in both cases. Autopsy neuropathologic examination of the older sibling at the age of 11 years revealed numerous giant axons, Rosenthal fibers, and gliosis throughout the brain and spinal cord and typical giant axons in the peripheral nerves. Electrophysiologic studies in the younger sibling indicated brain stem dysfunction, and her sural nerve biopsy revealed enlarged axons packed with neurofilaments. These patients illustrate that neurologic deficits of giant axonal neuropathy result from widespread lesions in the central, as well as peripheral (including autonomic), nervous systems. This occurrence of giant axonal neuropathy in two siblings supports a genetic origin of this disease. This is the first report of autopsy findings in giant axonal neuropathy in an affected sibling.

Entities:  

Mesh:

Year:  1990        PMID: 2168911     DOI: 10.1177/088307389000500316

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin.

Authors:  Bethany L Johnson-Kerner; Faizzan S Ahmad; Alejandro Garcia Diaz; John Palmer Greene; Steven J Gray; Richard Jude Samulski; Wendy K Chung; Rudy Van Coster; Paul Maertens; Scott A Noggle; Christopher E Henderson; Hynek Wichterle
Journal:  Hum Mol Genet       Date:  2014-11-04       Impact factor: 6.150

Review 2.  Dysfunctions of neuronal and glial intermediate filaments in disease.

Authors:  Ronald K H Liem; Albee Messing
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

3.  Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in giant axonal neuropathy.

Authors:  Eitan Israeli; Dilyan I Dryanovski; Paul T Schumacker; Navdeep S Chandel; Jeffrey D Singer; Jean P Julien; Robert D Goldman; Puneet Opal
Journal:  Hum Mol Genet       Date:  2016-03-21       Impact factor: 6.150

4.  Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

Authors:  Thibault Ganay; Alexia Boizot; Renaud Burrer; Jean Paul Chauvin; Pascale Bomont
Journal:  Mol Neurodegener       Date:  2011-04-12       Impact factor: 14.195

5.  Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy.

Authors:  Lori Sames; Allison Moore; Renee Arnold; Sean Ekins
Journal:  F1000Res       Date:  2014-04-03

6.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

7.  Advancing the pathologic phenotype of giant axonal neuropathy: early involvement of the ocular lens.

Authors:  Diane Armao; Thomas W Bouldin; Rachel M Bailey; Jody E Hooper; Diana X Bharucha; Steven J Gray
Journal:  Orphanet J Rare Dis       Date:  2019-02-01       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.